|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 4/30/10 Neogenix Oncology Inc 10-12G 32:4.4M RR Donnelley/FA |
Document/Exhibit Description Pages Size
1: 10-12G Form 10 HTML 860K
2: EX-3.1 Amended and Restated Articles of Incorporation HTML 53K
3: EX-3.2 Second Amended and Restated Bylaws HTML 98K
4: EX-4.1 Specimen Common Stock Certificate HTML 11K
5: EX-10.1 Employment Agreement Dated May 5, 2009 HTML 68K
14: EX-10.10 Form of Incentive Stock Option Agreement HTML 84K
15: EX-10.11 Lease by and Between the Registrant & Affiliated HTML 140K
Developers, Dated 03/17/2005
16: EX-10.12 First Modification of Lease, Dated 07/18/2008 HTML 36K
17: EX-10.13 Second Modification of Lease, Dated 01/22/2009 HTML 26K
18: EX-10.14 Third Modification of Lease, Dated 10/27/2009 HTML 52K
19: EX-10.15 Lease and License Agreement, Dated 04/28/2004 HTML 50K
20: EX-10.16 Amendment No. 1 to Lease and License Agreement, HTML 23K
Dated 05/28/2004
21: EX-10.17 Amendment No. 2 to Lease and License Agreement, HTML 23K
Dated 06/17/2005
22: EX-10.18 Amendment No. 3 to Lease and License Agreement , HTML 20K
Dated 07/02/2006
23: EX-10.19 Amendment No. 4 to Lease and License Agreement , HTML 21K
Dated 05/11/2007
6: EX-10.2 Amendment to Employment Agreement, Dated HTML 22K
02/19/2010
24: EX-10.20 Amendment No. 5 to Lease and License Agreement, HTML 23K
Dated 01/25/2008
25: EX-10.21 Amendment No. 6 to Lease and License Agreement, HTML 23K
Dated 03/21/2008
26: EX-10.22 Amendment No. 7 to Lease and License Agreement, HTML 22K
Dated 08/11/2008
27: EX-10.23 Amendment No. 9 to Lease and License Agreement, HTML 19K
Dated 04/30/2009
28: EX-10.24 Amendment No. 10 to Lease and License Agreement, HTML 22K
Dated 08/20/2009
29: EX-10.25 Amendment No. 10 (#2) to Lease and License HTML 21K
Agreement, Dated 09/29/2009
30: EX-10.26 Amendment No. 11 to Lease and License Agreement, HTML 22K
Dated 01/19/2010
31: EX-10.27 Amendment No. 12 to Lease and License Agreement, HTML 21K
Dated 02/12/2010
32: EX-10.28 Service Agreement HTML 361K
7: EX-10.3 Employment Agreement Dated May 5, 2009 HTML 69K
8: EX-10.4 Amendment to Employment Agreement, Dated HTML 22K
02/19/2010
9: EX-10.5 Employment Agreement Dated May 5, 2009 HTML 67K
10: EX-10.6 Amendment to Employment Agreement, Dated HTML 22K
02/19/2010
11: EX-10.7 2005 Employee, Director and Consultant Stock HTML 77K
Option Plan, as Amended
12: EX-10.8 2005 Amended and Restated Stock Option Plan HTML 90K
13: EX-10.9 Form of Non-Qualified Stock Option Agreement HTML 67K
| Amendment No. 9 to Lease and License Agreement, dated 04/30/2009 |
Exhibit 10.23
MARYLAND TECHNOLOGY DEVELOPMENT CENTER
LICENSE AGREEMENT
AMENDMENT 9
This addendum is made this 30 day of April, 2009, by and between MEDCO and Neogenix Oncology, Inc. (“Licensee”).
WHEREAS, MEDCO and Licensee have entered into a License Agreement dated April 28, 2004;
WHEREAS, Licensee currently occupies Labs #211 and #222, and offices #132, #261, #262, #267 and #317 in the Maryland Technology Development Center in Montgomery County, Maryland (the “Original Premises”);
WHEREAS Licensee wishes to reduce its office space within the Maryland Technology Development Center and MEDCO is willing to provide for such reduction based on the terms provided for below;
NOW, THEREFORE, in consideration of the mutual covenants and agreements stated herein, the parties agree as follows:
| 1. | Effective May 31, 2009, Licensee shall vacate office #132 (the “Reduction Premises”). |
| 2. | The aggregate Monthly Payment, to include the Monthly Payment for the Original Premises and the Reduction Premises provided for herein shall be as follows: |
| From June 1, 2009 to April 30, 2010 |
$ | 10,161 | |
| Renewal Term (if granted by MEDCO) From June 1, 2010 to April 30, 2011 |
$ | 11,177 | |
| 3. | All other provisions of the original License Agreement shall apply to this Amendment |
This Amendment may be signed in counterparts.
| FOR: |
Maryland Economic Development Corporation |
FOR: | Neogenix Oncology, Inc. | |||||
| BY: |
/s/ Robyn Sanches |
BY: |
| |||||
| Scheer Partners, Inc. Center Manager |
||||||||
| Date: |
5/22/09 | Date: | 4/30/09 | |||||
| BY: |
||||||||
| Executive Director, MEDCO |
||||||||
| Date: |
6/3/09 | |||||||
| This ‘10-12G’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 4/30/11 | None on these Dates | |||
| 6/1/10 | ||||
| Filed on: | 4/30/10 | |||
| 6/1/09 | ||||
| 5/31/09 | ||||
| 4/28/04 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/03/10 SEC UPLOAD¶ 10/20/17 1:49K Neogenix Oncology Inc. 7/07/10 SEC UPLOAD¶ 10/20/17 1:61K Neogenix Oncology Inc. 6/24/10 SEC UPLOAD¶ 10/20/17 1:95K Neogenix Oncology Inc. 5/24/10 SEC UPLOAD¶ 10/20/17 1:125K Neogenix Oncology Inc. |
